Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines

by Jillian C. Kohler, Tim K. Mackey
Published 2020-06-01

Social capital and public health: responding to the COVID-19 pandemic

by Anna S. Y. Wong, Jillian C. Kohler
Published 2020-09-01

The Global Fund: why anti-corruption, transparency and accountability matter

by Zhihao Chang, Violet Rusu, Jillian C. Kohler
Published 2021-09-01

Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

by Taryn Vian, Jillian C. Kohler, Gilles Forte, Deirdre Dimancesco
Published 2017-06-01

Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process

by Anna S. Y. Wong, Clarke B. Cole, Jillian C. Kohler
Published 2021-08-01

A framework for the management of donated medical devices based on perspectives of frontline public health care staff in Ghana

by Dinsie B Williams, Jillian C Kohler, Andrew Howard, Zubin Austin, Yu-Ling Cheng
Published 2020-09-01

Transparency and accountability in the negotiation of the US-Mexico-Canada trade agreement: the case of pharmaceuticals

by Anna S Y Wong, BSc, Clarke B Cole, MSc, Jillian C Kohler, PhD
Published 2021-03-01

Detection of self-reported experiences with corruption on twitter using unsupervised machine learning

by Jiawei Li, Wen-Hao Chen, Qing Xu, Neal Shah, Jillian C. Kohler, Tim K. Mackey
Published 2020-01-01